Galleri Multi-Cancer Test (50+ cancers)

Galleri Multi-Cancer Test (50+ cancers) is a cancer screening markers biomarker that Advanced test detecting 50+ cancer types The normal reference range is Negative result preferred;positive requires imaging. Regular testing helps track changes and identify potential health issues early.

Galleri Multi-Cancer Test (50+ cancers) is not commonly included in standard blood test panels and may require special ordering or be available as an add-on test.

For most people, testing Galleri Multi-Cancer Test (50+ cancers) 2-4 times per year is recommended to establish baseline levels and track trends. If you have abnormal results or are actively working to optimize this biomarker, more frequent testing (quarterly) may be beneficial. Always consult with your healthcare provider for personalized testing frequency recommendations.

The standard laboratory reference range for Galleri Multi-Cancer Test (50+ cancers) is Negative result preferred;positive requires imaging. However, many functional medicine practitioners recommend tighter "optimal" ranges for peak health and performance. Your ideal range may vary based on your age, sex, health goals, and other individual factors. Work with a healthcare provider familiar with optimal ranges to determine your target levels.

Most direct-to-consumer blood testing services that include Galleri Multi-Cancer Test (50+ cancers) provide the physician order as part of their service. However, some states have restrictions on direct-to-consumer testing. Check with your chosen provider about availability in your state and whether they provide the necessary physician authorization.

Detects cell-free DNA from 50+ cancer types. Early detection of multiple cancers with single blood test. Signals cancer origin for targeted follow-up.